Landscapes / Companies
Vividion Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 4 in all
Trials
4 active
5 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Jun 2028Phase 2 trial completes | |||
| Next date | 30 Jun 2028 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Colorectal Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Aug 2027Phase 1 trial completes | |||
| Next date | 1 Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Aug 2030Phase 1 trial completes | |||
| Next date | 31 Aug 2030 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- No active trial
- VVD-130850
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021